Skip to main content
. 2019 Oct 18;1(6):366–375. doi: 10.1016/j.xkme.2019.07.015

Figure 3.

Figure 3

Changes in patient-reported outcome symptoms postsclerotherapy (n = 56). Among 33, 18, and 22 patients who had flank/back pain, abdominal pain, and abdominal distension before sclerotherapy, 70% (23/33), 78% (14/18), and 59% (13/22), respectively, experienced improvement in symptoms postsclerotherapy. None, mild, moderate, and significant refer to the degree of improvement in symptoms. Abbreviation: NBS, no baseline symptoms.